Log in to save to my catalogue

Abatacept blocks anti-citrullinated protein antibody and rheumatoid factor mediated cytokine product...

Abatacept blocks anti-citrullinated protein antibody and rheumatoid factor mediated cytokine product...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a71ffcbebe68475c96b16a3bf722cf5b

Abatacept blocks anti-citrullinated protein antibody and rheumatoid factor mediated cytokine production in human macrophages in IDO-dependent manner

About this item

Full title

Abatacept blocks anti-citrullinated protein antibody and rheumatoid factor mediated cytokine production in human macrophages in IDO-dependent manner

Publisher

England: BioMed Central Ltd

Journal title

Arthritis research & therapy, 2018-02, Vol.20 (1), p.24-24, Article 24

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The anti-inflammatory effect of abatacept is most pronounced in patients with high-titer autoantibodies (including anticitrullinated protein antibodies [ACPA] and rheumatoid factor [RF]). Considering that autoantibodies trigger inflammatory cytokine production by monocytes and that abatacept binds to monocytes, influencing their functional state, w...

Alternative Titles

Full title

Abatacept blocks anti-citrullinated protein antibody and rheumatoid factor mediated cytokine production in human macrophages in IDO-dependent manner

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a71ffcbebe68475c96b16a3bf722cf5b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a71ffcbebe68475c96b16a3bf722cf5b

Other Identifiers

ISSN

1478-6362,1478-6354

E-ISSN

1478-6362

DOI

10.1186/s13075-018-1527-x

How to access this item